Skip to main content
ukiyo journal - 日本と世界をつなぐ新しいニュースメディア Logo
  • All Articles
  • 🗒️ Register
  • 🔑 Login
    • 日本語
    • 中文
    • Español
    • Français
    • 한국어
    • Deutsch
    • ภาษาไทย
    • हिंदी
Cookie Usage

We use cookies to improve our services and optimize user experience. Privacy Policy and Cookie Policy for more information.

Cookie Settings

You can configure detailed settings for cookie usage.

Essential Cookies

Cookies necessary for basic site functionality. These cannot be disabled.

Analytics Cookies

Cookies used to analyze site usage and improve our services.

Marketing Cookies

Cookies used to display personalized advertisements.

Functional Cookies

Cookies that provide functionality such as user settings and language selection.

Breaking the "Chain of Inheritance" from Mother to Child: The Achievement of Mitochondrial Therapy in the UK - Eight Babies Saved from Genetic Disorders through Mitochondrial Donation

Breaking the "Chain of Inheritance" from Mother to Child: The Achievement of Mitochondrial Therapy in the UK - Eight Babies Saved from Genetic Disorders through Mitochondrial Donation

2025年07月18日 02:11

1. The Fatal Risks of the "Powerhouse"

The cell's energy factory, mitochondria, contains 37 unique DNA sequences that are maternally inherited. Even slight mutations in these genes can lead to mitochondrial diseases, resulting in seizures, heart disorders, and early death. Though rare, occurring in 2 out of every 10,000 births, there is no cure, and the fear of passing it on weighs heavily on women in affected families.Live Science


2. The UK's Pioneering "Third DNA"

In 2015, the UK Parliament became the first in the world to legalize mitochondrial donation. Australia followed suit in 2022, but the US FDA prohibits clinical trials. Under this legal precedent, Newcastle University, Monash University, and the NHS conducted a large-scale trial. The study employed Pronuclear Transfer (PNT), which involves transferring only the nucleus during the pronuclear stage of the fertilized egg, to maximize safety.Live ScienceNewcastle University


3. Trial Design and Results

  • Subjects: 22 women with extremely high mitochondrial mutation loads for whom standard preimplantation genetic testing (PGT) is ineffective

  • Methods: Fertilization by ICSI → Removal of pronuclei → Nuclear transfer to donor egg → Uterine transfer after culture

  • Results: Pregnancy rate of 36% (8/22), resulting in the birth of 8 children, 4 boys and 4 girls. All showed age-appropriate development at 1.5 to 24 months.Live Science


4. Residual Mitochondria and Long-term Follow-up

Due to the procedure, there is a possibility of 0.1-5% maternal mitochondria mixing with the nucleus. In this study, it was below the critical threshold of 20%, but the research team emphasized that this is a risk reduction, not prevention, and plans to add neurodevelopmental assessments up to age 5.Live ScienceSTAT


5. Evaluation by Medical and Ethical Communities

In a commentary published simultaneously in NEJM, Professor Robin Lovell-Badge of the Crick Institute described the outcomes as "long-awaited and favorable," while suggesting improvements to the method and enhanced follow-up. STAT and the Guardian raised ethical concerns, questioning whether this is a step toward "designer babies," reigniting debates over regulatory relaxation in the US.The GuardianSTAT


6. Enthusiasm and Confusion Spreading on Social Media

The day after the announcement, "#mitodonation" trended on X (formerly Twitter), with comments like "Hope for families freed from the fate of genetics" (science journalist) and "Could this be fertile ground for genome editing next?" On Reddit /r/UpliftingNews, there was widespread praise, calling it "good news for families who lost children to mitochondrial disease." Meanwhile, threads warning of "engineered babies" and "treading into the realm of gods" were also active.Reddit


7. Voices of Affected Families

A statement from a mother included in the paper described it as "the clouds have cleared," and the UK Mitochondrial Disease Patient Association commented on it as a "revolution in family planning." However, with treatment costs estimated at £80,000, there are concerns about "technological disparity" in countries where legal frameworks and subsidies are lacking.Live Science


8. Ethical Issues Overview

Points of DebateArguments in FavorConcerns and Opposition
Reproductive FreedomReducing genetic disease risks and avoiding sufferingAccess to technology is limited to the wealthy
Generational Inheritance of Genetic ModificationsMitochondrial DNA is independent of nuclear DNA, limiting impactCannot obtain consent from future generations
Slippery Slope ArgumentStrict indications and regulations prevent abuseRisk of expanding to cosmetic uses


9. Future Outlook and Challenges

  1. Long-term Safety Data: 10-year follow-up on metabolic, neurological, and reproductive functions is essential

  2. Reducing Technological Costs: Efficiency through robotic micromanipulation and AI culture monitoring

  3. Creating International Rules: Governance modeled after WHO's "Human Genome Editing Framework"

  4. Ethics of Patient Recruitment: Establishing information provision and psychological support systems


10. Conclusion

Mitochondrial donation has become a turning point, breaking the "chain of hereditary diseases across three generations" and merging regenerative and reproductive medicine. Although the technology is in its infancy, as evidenced by the smiles of eight children, the future enabled by "three-person DNA" has indeed begun. Careful debate and transparent data sharing will be key to keeping the light of hope alive.



Reference Articles

8 babies spared from potentially deadly inherited diseases through new mitochondrial donation trial
Source: https://www.livescience.com/health/genetics/8-babies-spared-from-potentially-deadly-inherited-diseases-through-new-mitochondrial-donation-trial

← Back to Article List

Contact |  Terms of Service |  Privacy Policy |  Cookie Policy |  Cookie Settings

© Copyright ukiyo journal - 日本と世界をつなぐ新しいニュースメディア All rights reserved.